ISELIN, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of ...
FAYETTEVILLE, GA, UNITED STATES, March 10, 2026 /EINPresswire.com/ -- Chronic diabetic wounds fail to heal because ...
A Nasdaq-listed biotechnology company repositioned as a global platform for acquiring and advancing clinical-stage assets. NovaBridge Biosciences is built around two principal programs, givastomig in ...
Leerink Global Healthcare Conference 2026 March 10, 2026 11:20 AM EDTCompany ParticipantsScott Reents - Executive VP & ...
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, developm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results